+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Monoclonal Antibodies Market Research Report by Source Type (Chimeric, Human, Humanized, and Murine), by Production Type (In Vitro and In Vivo), by Indication, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5311207
  • Report
  • March 2021
  • Region: Global
  • 195 pages
  • 360iResearch™
UP TO OFF
until Jun 30th 2021
1 of 4
The Global Monoclonal Antibodies Market to Grow USD 153,693.39 Million by 2025, at a CAGR of 11.38%

FEATURED COMPANIES

  • Abbott Laboratories
  • ADC Therapeutics
  • Astellas Pharma Inc
  • Biogen Idec Inc.
  • F. Hoffmann-La Roche AG
  • Mylan N.V.
  • MORE
Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Monoclonal Antibodies Market is expected to grow from USD 89,652.58 Million in 2020 to USD 153,693.39 Million by the end of 2025.
2. The Global Monoclonal Antibodies Market is expected to grow from EUR 78,609.08 Million in 2020 to EUR 134,761.28 Million by the end of 2025.
3. The Global Monoclonal Antibodies Market is expected to grow from GBP 69,883.64 Million in 2020 to GBP 119,803.07 Million by the end of 2025.
4. The Global Monoclonal Antibodies Market is expected to grow from JPY 9,568,202.08 Million in 2020 to JPY 16,402,979.30 Million by the end of 2025.
5. The Global Monoclonal Antibodies Market is expected to grow from AUD 130,187.46 Million in 2020 to AUD 223,183.24 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Monoclonal Antibodies to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Source Type, the Monoclonal Antibodies Market is examined across Chimeric, Human, Humanized, and Murine.

Based on Production Type, the Monoclonal Antibodies Market is examined across In Vitro and In Vivo.

Based on Indication, the Monoclonal Antibodies Market is examined across Autoimmune Diseases, Cancer, Infectious Diseases, Inflammatory Diseases, and Microbial Diseases.

Based on End-User, the Monoclonal Antibodies Market is examined across Hospitals and Research Institutes.

Based on Geography, the Monoclonal Antibodies Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Monoclonal Antibodies Market including Abbott Laboratories, AbbVie, Inc, AbGenomics, ADC Therapeutics, ALMAC Group, Amgen Inc., Astellas Pharma Inc, AstraZeneca PLC, Bayer AG, Biogen Idec Inc., Bristol Myers Squibb, Daiichi Sankyo Company, Limited, Eli Lilly and Company, F. Hoffmann-La Roche AG, GenScript Biotech Corporation, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Mylan N.V., Novartis International AG, Novo Nordisk A/S, Pfizer Inc, Sanofi S.A., Seagen Inc., Shanghai Junshi Biosciences Co., Ltd., and Thermo Fisher Scientific, Inc.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Monoclonal Antibodies Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Monoclonal Antibodies Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Monoclonal Antibodies Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Monoclonal Antibodies Market?
4. What is the competitive strategic window for opportunities in the Global Monoclonal Antibodies Market?
5. What are the technology trends and regulatory frameworks in the Global Monoclonal Antibodies Market?
6. What are the modes and strategic moves considered suitable for entering the Global Monoclonal Antibodies Market?
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • ADC Therapeutics
  • Astellas Pharma Inc
  • Biogen Idec Inc.
  • F. Hoffmann-La Roche AG
  • Mylan N.V.
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. End-User Outlook
3.4. Indication Outlook
3.5. Production Type Outlook
3.6. Source Type Outlook
3.7. Geography Outlook
3.8. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of cost-efficient biosimilar monoclonal antibodies
5.1.1.2. Rising incidence of cancer and other chronic diseases
5.1.1.3. Increasing R&D activities in genomics coupled with the advent of technologically advanced genetic platforms
5.1.2. Restraints
5.1.2.1. Pricing of therapeutic mAbs are expensive
5.1.3. Opportunities
5.1.3.1. High adoption rate in developing countries
5.1.3.2. Substantial increase in the number of approvals per year
5.1.4. Challenges
5.1.4.1. Limitation in current manufacturing and purification processes (risk of contamination) affect production capacity and led to increasing cost
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Global Monoclonal Antibodies Market, By Source Type
6.1. Introduction
6.2. Chimeric
6.3. Human
6.4. Humanized
6.5. Murine

7. Global Monoclonal Antibodies Market, By Production Type
7.1. Introduction
7.2. In Vitro
7.3. In Vivo

8. Global Monoclonal Antibodies Market, By Indication
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Cancer
8.4. Infectious Diseases
8.5. Inflammatory Diseases
8.6. Microbial Diseases

9. Global Monoclonal Antibodies Market, By End-User
9.1. Introduction
9.2. Hospitals
9.3. Research Institutes

10. Americas Monoclonal Antibodies Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Monoclonal Antibodies Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand

12. Europe, Middle East & Africa Monoclonal Antibodies Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Abbott Laboratories
14.2. AbbVie, Inc
14.3. AbGenomics
14.4. ADC Therapeutics
14.5. ALMAC Group
14.6. Amgen Inc.
14.7. Astellas Pharma Inc
14.8. AstraZeneca PLC
14.9. Bayer AG
14.10. Biogen Idec Inc.
14.11. Bristol Myers Squibb
14.12. Daiichi Sankyo Company, Limited
14.13. Eli Lilly and Company
14.14. F. Hoffmann-La Roche AG
14.15. GenScript Biotech Corporation
14.16. GlaxoSmithKline PLC
14.17. Johnson & Johnson Services, Inc.
14.18. Merck & Co., Inc.
14.19. Mylan N.V.
14.20. Novartis International AG
14.21. Novo Nordisk A/S
14.22. Pfizer Inc
14.23. Sanofi S.A.
14.24. Seagen Inc.
14.25. Shanghai Junshi Biosciences Co., Ltd.
14.26. Thermo Fisher Scientific, Inc

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

List of Figures
Figure 1. Global Monoclonal Antibodies Market: Research Process
Figure 2. Global Monoclonal Antibodies Market: Research Execution
Figure 3. Global Monoclonal Antibodies Market Size, 2020 Vs 2025 (USD Million)
Figure 4. Global Monoclonal Antibodies Market Size, by End-User, 2020 (USD Million)
Figure 5. Global Monoclonal Antibodies Market Size, by Indication, 2020 (USD Million)
Figure 6. Global Monoclonal Antibodies Market Size, by Production Type, 2020 (USD Million)
Figure 7. Global Monoclonal Antibodies Market Size, by Source Type, 2020 (USD Million)
Figure 8. Global Monoclonal Antibodies Market Size, by Geography, 2020 (USD Million)
Figure 9. Global Monoclonal Antibodies Market Size, 2018-2025 (USD Million)
Figure 10. Global Monoclonal Antibodies Market Size, by Geography, 2020 Vs 2025 (%)
Figure 11. Global Monoclonal Antibodies Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 12. Competitive Strategic Window for Global Monoclonal Antibodies Market Size, by Geography, 2025
Figure 13. Global Monoclonal Antibodies Market: Market Dynamics
Figure 14. Global Monoclonal Antibodies Market: Porters Five Forces Analysis
Figure 15. Global Monoclonal Antibodies Market Size, by Source Type, 2020 Vs 2025 (%)
Figure 16. Global Monoclonal Antibodies Market Size, by Source Type, 2020 Vs 2025 (USD Million)
Figure 17. Competitive Strategic Window for Global Monoclonal Antibodies Market Size, by Source Type, 2025
Figure 18. Global Monoclonal Antibodies Market Size, by Chimeric, 2020 Vs 2025 (USD Million)
Figure 19. Global Monoclonal Antibodies Market Size, by Human, 2020 Vs 2025 (USD Million)
Figure 20. Global Monoclonal Antibodies Market Size, by Humanized, 2020 Vs 2025 (USD Million)
Figure 21. Global Monoclonal Antibodies Market Size, by Murine, 2020 Vs 2025 (USD Million)
Figure 22. Global Monoclonal Antibodies Market Size, by Production Type, 2020 Vs 2025 (%)
Figure 23. Global Monoclonal Antibodies Market Size, by Production Type, 2020 Vs 2025 (USD Million)
Figure 24. Competitive Strategic Window for Global Monoclonal Antibodies Market Size, by Production Type, 2025
Figure 25. Global Monoclonal Antibodies Market Size, by in Vitro, 2020 Vs 2025 (USD Million)
Figure 26. Global Monoclonal Antibodies Market Size, by in Vivo, 2020 Vs 2025 (USD Million)
Figure 27. Global Monoclonal Antibodies Market Size, by Indication, 2020 Vs 2025 (%)
Figure 28. Global Monoclonal Antibodies Market Size, by Indication, 2020 Vs 2025 (USD Million)
Figure 29. Competitive Strategic Window for Global Monoclonal Antibodies Market Size, by Indication, 2025
Figure 30. Global Monoclonal Antibodies Market Size, by Autoimmune Diseases, 2020 Vs 2025 (USD Million)
Figure 31. Global Monoclonal Antibodies Market Size, by Cancer, 2020 Vs 2025 (USD Million)
Figure 32. Global Monoclonal Antibodies Market Size, by Infectious Diseases, 2020 Vs 2025 (USD Million)
Figure 33. Global Monoclonal Antibodies Market Size, by Inflammatory Diseases, 2020 Vs 2025 (USD Million)
Figure 34. Global Monoclonal Antibodies Market Size, by Microbial Diseases, 2020 Vs 2025 (USD Million)
Figure 35. Global Monoclonal Antibodies Market Size, by End-User, 2020 Vs 2025 (%)
Figure 36. Global Monoclonal Antibodies Market Size, by End-User, 2020 Vs 2025 (USD Million)
Figure 37. Competitive Strategic Window for Global Monoclonal Antibodies Market Size, by End-User, 2025
Figure 38. Global Monoclonal Antibodies Market Size, by Hospitals, 2020 Vs 2025 (USD Million)
Figure 39. Global Monoclonal Antibodies Market Size, by Research Institutes, 2020 Vs 2025 (USD Million)
Figure 40. Americas Monoclonal Antibodies Market Size, by Geography, 2020 Vs 2025 (%)
Figure 41. Americas Monoclonal Antibodies Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 42. Competitive Strategic Window for Americas Monoclonal Antibodies Market Size, by Geography, 2025
Figure 43. Argentina Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 44. Brazil Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 45. Canada Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 46. Mexico Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 47. United States Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 48. Asia-Pacific Monoclonal Antibodies Market Size, by Geography, 2020 Vs 2025 (%)
Figure 49. Asia-Pacific Monoclonal Antibodies Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 50. Competitive Strategic Window for Asia-Pacific Monoclonal Antibodies Market Size, by Geography, 2025
Figure 51. Australia Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 52. China Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 53. India Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 54. Indonesia Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 55. Japan Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 56. Malaysia Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 57. Philippines Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 58. South Korea Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 59. Thailand Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 60. Europe, Middle East & Africa Monoclonal Antibodies Market Size, by Geography, 2020 Vs 2025 (%)
Figure 61. Europe, Middle East & Africa Monoclonal Antibodies Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 62. Competitive Strategic Window for Europe, Middle East & Africa Monoclonal Antibodies Market Size, by Geography, 2025
Figure 63. France Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 64. Germany Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 65. Italy Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 66. Netherlands Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 67. Qatar Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 68. Russia Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 69. Saudi Arabia Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 70. South Africa Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 71. Spain Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 72. United Arab Emirates Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 73. United Kingdom Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD Million)
Figure 74. Global Monoclonal Antibodies Market: Fpnv Positioning Matrix
Figure 75. Global Monoclonal Antibodies Market: Market Share Analysis
Figure 76. Global Monoclonal Antibodies Market: Competitor SWOT Analysis
Figure 77. Competitive Scenario Analysis in Global Monoclonal Antibodies Market, by Type

List of Tables
Table 1. Currency Conversion Rates
Table 2. Global Monoclonal Antibodies Market Size, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 3. Global Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 4. Global Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 5. Global Monoclonal Antibodies Market Size, by Chimeric, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 6. Global Monoclonal Antibodies Market Size, by Human, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 7. Global Monoclonal Antibodies Market Size, by Humanized, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 8. Global Monoclonal Antibodies Market Size, by Murine, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 9. Global Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 10. Global Monoclonal Antibodies Market Size, by in Vitro, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 11. Global Monoclonal Antibodies Market Size, by in Vivo, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 12. Global Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 13. Global Monoclonal Antibodies Market Size, by Autoimmune Diseases, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 14. Global Monoclonal Antibodies Market Size, by Cancer, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 15. Global Monoclonal Antibodies Market Size, by Infectious Diseases, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 16. Global Monoclonal Antibodies Market Size, by Inflammatory Diseases, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 17. Global Monoclonal Antibodies Market Size, by Microbial Diseases, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 18. Global Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 19. Global Monoclonal Antibodies Market Size, by Hospitals, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 20. Global Monoclonal Antibodies Market Size, by Research Institutes, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 21. Americas Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 22. Americas Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 23. Americas Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 24. Americas Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 25. Americas Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 26. Argentina Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 27. Argentina Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 28. Argentina Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 29. Argentina Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 30. Brazil Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 31. Brazil Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 32. Brazil Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 33. Brazil Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 34. Canada Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 35. Canada Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 36. Canada Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 37. Canada Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 38. Mexico Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 39. Mexico Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 40. Mexico Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 41. Mexico Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 42. United States Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 43. United States Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 44. United States Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 45. United States Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 46. Asia-Pacific Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 47. Asia-Pacific Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 48. Asia-Pacific Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 49. Asia-Pacific Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 50. Asia-Pacific Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 51. Australia Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 52. Australia Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 53. Australia Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 54. Australia Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 55. China Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 56. China Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 57. China Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 58. China Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 59. India Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 60. India Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 61. India Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 62. India Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 63. Indonesia Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 64. Indonesia Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 65. Indonesia Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 66. Indonesia Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 67. Japan Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 68. Japan Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 69. Japan Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 70. Japan Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 71. Malaysia Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 72. Malaysia Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 73. Malaysia Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 74. Malaysia Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 75. Philippines Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 76. Philippines Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 77. Philippines Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 78. Philippines Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 79. South Korea Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 80. South Korea Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 81. South Korea Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 82. South Korea Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 83. Thailand Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 84. Thailand Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 85. Thailand Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 86. Thailand Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 87. Europe, Middle East & Africa Monoclonal Antibodies Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 88. Europe, Middle East & Africa Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 89. Europe, Middle East & Africa Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 90. Europe, Middle East & Africa Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 91. Europe, Middle East & Africa Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 92. France Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 93. France Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 94. France Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 95. France Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 96. Germany Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 97. Germany Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 98. Germany Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 99. Germany Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 100. Italy Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 101. Italy Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 102. Italy Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 103. Italy Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 104. Netherlands Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 105. Netherlands Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 106. Netherlands Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 107. Netherlands Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 108. Qatar Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 109. Qatar Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 110. Qatar Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 111. Qatar Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 112. Russia Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 113. Russia Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 114. Russia Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 115. Russia Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 116. Saudi Arabia Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 117. Saudi Arabia Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 118. Saudi Arabia Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 119. Saudi Arabia Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 120. South Africa Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 121. South Africa Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 122. South Africa Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 123. South Africa Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 124. Spain Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 125. Spain Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 126. Spain Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 127. Spain Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 128. United Arab Emirates Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 129. United Arab Emirates Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 130. United Arab Emirates Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 131. United Arab Emirates Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 132. United Kingdom Monoclonal Antibodies Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 133. United Kingdom Monoclonal Antibodies Market Size, by Indication, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 134. United Kingdom Monoclonal Antibodies Market Size, by Production Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 135. United Kingdom Monoclonal Antibodies Market Size, by Source Type, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
Table 136. Global Monoclonal Antibodies Market: Scores
Table 137. Global Monoclonal Antibodies Market: Business Strategy
Table 138. Global Monoclonal Antibodies Market: Product Satisfaction
Table 139. Global Monoclonal Antibodies Market: Ranking
Table 140. Global Monoclonal Antibodies Market: Merger & Acquisition
Table 141. Global Monoclonal Antibodies Market: Agreement, Collaboration, & Partnership
Table 142. Global Monoclonal Antibodies Market: New Product Launch & Enhancement
Table 143. Global Monoclonal Antibodies Market: Investment & Funding
Table 144. Global Monoclonal Antibodies Market: Award, Recognition, & Expansion
Table 145. Global Monoclonal Antibodies Market: License & Pricing
Note: Product cover images may vary from those shown
3 of 4
  • Abbott Laboratories
  • AbbVie, Inc
  • AbGenomics
  • ADC Therapeutics
  • ALMAC Group
  • Amgen Inc.
  • Astellas Pharma Inc
  • AstraZeneca PLC
  • Bayer AG
  • Biogen Idec Inc.
  • Bristol Myers Squibb
  • Daiichi Sankyo Company, Limited
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GenScript Biotech Corporation
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis International AG
  • Novo Nordisk A/S
  • Pfizer Inc
  • Sanofi S.A.
  • Seagen Inc.
  • Shanghai Junshi Biosciences Co., Ltd.
  • Thermo Fisher Scientific, Inc
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll